Aspen Aerogels, Inc. (NYSE:ASPN) Given Average Recommendation of “Hold” by Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN) has received a consensus recommendation of “Hold” from the ten research firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $12.6667.

A number of brokerages have recently issued reports on ASPN. Canaccord Genuity Group cut their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a research note on Friday, November 7th. Barclays dropped their price objective on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a report on Friday, November 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, December 29th. Finally, Zacks Research lowered shares of Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th.

Insider Activity at Aspen Aerogels

In related news, CEO Donald R. Young sold 56,845 shares of the firm’s stock in a transaction dated Thursday, November 13th. The shares were sold at an average price of $3.23, for a total value of $183,609.35. Following the completion of the sale, the chief executive officer owned 494,011 shares in the company, valued at $1,595,655.53. This trade represents a 10.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 3.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On Aspen Aerogels

A number of large investors have recently added to or reduced their stakes in the business. Gagnon Securities LLC acquired a new position in shares of Aspen Aerogels during the 2nd quarter valued at about $11,243,000. Y Intercept Hong Kong Ltd acquired a new stake in shares of Aspen Aerogels in the second quarter worth approximately $484,000. Palogic Value Management L.P. grew its holdings in Aspen Aerogels by 43.5% in the second quarter. Palogic Value Management L.P. now owns 610,000 shares of the construction company’s stock valued at $3,611,000 after purchasing an additional 185,000 shares during the period. SG Americas Securities LLC increased its position in Aspen Aerogels by 98.6% during the second quarter. SG Americas Securities LLC now owns 133,821 shares of the construction company’s stock worth $792,000 after purchasing an additional 66,427 shares during the last quarter. Finally, Federated Hermes Inc. purchased a new position in Aspen Aerogels during the second quarter worth approximately $10,459,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $2.90 on Monday. The stock has a market capitalization of $239.27 million, a P/E ratio of -0.78 and a beta of 2.94. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.33 and a current ratio of 3.94. Aspen Aerogels has a 1 year low of $2.80 and a 1 year high of $14.30. The company’s fifty day moving average is $3.92 and its two-hundred day moving average is $6.01.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The firm had revenue of $73.02 million during the quarter, compared to analysts’ expectations of $73.42 million. During the same period in the previous year, the firm earned ($0.17) EPS. The firm’s revenue was down 37.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, sell-side analysts predict that Aspen Aerogels will post 0.17 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.